Taken together, a combination of traditional risk factors such as hypertension and dyslipidemia, and nontraditional ones, especially aPL, inflammation, and low anti‐PC are implicated in the increased risk of CVD in SLE. This evidence concerns the gene FASLG and systemic lupus erythematosus.